5244

Syncom Formulations (India) Limited Stock Price

BSE:524470 Community·₹15.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

524470 Share Price Performance

₹16.36
-4.08 (-19.96%)
₹16.36
-4.08 (-19.96%)
Price ₹16.36

524470 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
2 Rewards

Syncom Formulations (India) Limited Key Details

₹4.9b

Revenue

₹3.2b

Cost of Revenue

₹1.7b

Gross Profit

₹1.2b

Other Expenses

₹575.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 14, 2025
0.61
34.91%
11.64%
1.3%
View Full Analysis

About 524470

Founded
1988
Employees
744
CEO
Vijay Bankda
WebsiteView website
www.syncomformulations.com

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, and the right nutrition products under the Cratus brand. In addition, the company offers its pharmaceutical formulation products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.

Recent 524470 News & Updates

Recent updates

No updates